Allianz Asset Management GmbH Has $2.85 Million Holdings in Revvity Inc. $RVTY

Allianz Asset Management GmbH raised its stake in Revvity Inc. (NYSE:RVTY) by 22.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,548 shares of the company’s stock after purchasing an additional 5,861 shares during the period. Allianz Asset Management GmbH’s holdings in Revvity were worth $2,853,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in RVTY. Campbell & CO Investment Adviser LLC bought a new stake in shares of Revvity in the third quarter worth about $905,000. Amundi raised its holdings in Revvity by 157.0% during the 2nd quarter. Amundi now owns 519,987 shares of the company’s stock worth $52,467,000 after buying an additional 317,643 shares during the period. Invesco Ltd. lifted its stake in Revvity by 25.8% in the second quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock valued at $213,481,000 after buying an additional 452,343 shares in the last quarter. SG Americas Securities LLC boosted its holdings in shares of Revvity by 531.8% in the third quarter. SG Americas Securities LLC now owns 42,947 shares of the company’s stock valued at $3,764,000 after buying an additional 36,149 shares during the period. Finally, Korea Investment CORP increased its position in shares of Revvity by 61.7% during the second quarter. Korea Investment CORP now owns 71,265 shares of the company’s stock worth $6,893,000 after acquiring an additional 27,200 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

Shares of Revvity stock opened at $101.14 on Thursday. Revvity Inc. has a 52 week low of $81.36 and a 52 week high of $120.39. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36. The business has a 50 day moving average price of $103.80 and a 200-day moving average price of $95.75. The company has a market cap of $11.47 billion, a PE ratio of 48.62, a price-to-earnings-growth ratio of 2.22 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same quarter in the prior year, the company posted $1.42 earnings per share. Revvity’s revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s dividend payout ratio is presently 13.46%.

Revvity declared that its board has initiated a stock repurchase plan on Monday, October 27th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 8.7% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on RVTY. TD Cowen reaffirmed a “hold” rating on shares of Revvity in a research note on Tuesday, February 3rd. Evercore upped their price objective on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 3rd. Barclays lifted their target price on Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Tuesday, February 3rd. Bank of America downgraded Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price target for the company. in a research report on Monday, December 15th. Finally, The Goldman Sachs Group started coverage on shares of Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price objective on the stock. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $113.67.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.